Neuroprotective Effects of Danshen Chuanxiongqin Injection Against Ischemic Stroke: Metabolomic Insights by UHPLC-Q-Orbitrap HRMS Analysis
Peipei Zhou(St. Jude Children's Research Hospital), Xiaojian Zhang(Zhejiang International Studies University), Zhi Sun(First Affiliated Hospital of Zhengzhou University), Yingying Shi(Nankai University), Jun Zhang(Huazhong Agricultural University), Shuzhang Du(First Affiliated Hospital of Zhengzhou University), Liwei Liu(Shenzhen University), Lin Zhou(First Affiliated Hospital of Zhengzhou University), Lihua Zuo(Shenyang Pharmaceutical University), Jing Yang(First Affiliated Hospital of Zhengzhou University), Jian Kang(Gansu Provincial Hospital), Zhuolun Li(First Affiliated Hospital of Zhengzhou University), Shuhong Liang(First Affiliated Hospital of Zhengzhou University)
Cited by 25
Related Papers
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
|Signal Transduction and Targeted Therapy|2021|403
Caffeine
|Unknown|2016|300
Caffeine: Toward Uniformed Representation and Acceleration for Deep Convolutional Neural Networks
|IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems|2018|268
mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions
|Immunological Reviews|2020|188